May 27 2022




Recommendations

There is no information available regarding the use of this substance during breastfeeding, so that, if deemed necessary its administration, it is recommended to use another anti-inflammatory.

Warning of the manufacturer:

The postnatal development was not affected, even if the active metabolite of nabumetone (6MNA) is detected in the milk of lactating rats. Due to lack of experience with the use of nabumetone during lactation in humans, its use should be restricted to those cases in which the potential benefit to the mother justifies the potential risk to the infant.

Updated:24.02.08